Bicycle Therapeutics plc (BCYC)
NASDAQ·Healthcare·Biotechnology
$4.04
+0.37%
Mkt Cap $372.77M
Analyst Ratings
No recent rating data.
Price Target (13 analysts)
$11.00
Range $8.00 – $13.00
Implied Upside
+172.6%
Consensus $11.00 vs current $4.04
NASDAQ·Healthcare·Biotechnology
$4.04
+0.37%
Mkt Cap $372.77M
No recent rating data.
Price Target (13 analysts)
$11.00
Range $8.00 – $13.00
+172.6%
Consensus $11.00 vs current $4.04